Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Galena Biopharma
GALE
Healthcare
Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive...
breast cancer."
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GALE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 21, 2013 5:12pm
Biotech Bonanza
Biotech companies often return incredible investment rewards. Ten-fold, twenty-fold, and even a hundred-fold return can occur over time after a company announces the approval of a breakthrough drug
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 14, 2013 7:45pm
Galena Biopharma, Inc. (GALE) Fills Gap in Breakthrough Can
Galena Biopharma, Inc. (GALE) Fills Gap in Breakthrough Cancer Treatment Opioid analgesics (painkillers) are commonly used to treat chronic pain, such as with individuals suffering from cancer. Long
...more
Quimbaya Gold Inc. Announces Private Placement and Closing of First Tranche
posted Jun 07, 2024 9:00am by
Quimbaya Gold Inc.
-
|
Quimbaya Gold announces it is completing a private placement of units of the Company ("Units") for up to an aggregate of $3,000,000 (6,000,000 Units) at a price of $0.50 per Unit ...read more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 07, 2013 7:43pm
Galena Biopharma, Inc. (GALE) Announces Oral Presentation on
Galena Biopharma, Inc. (GALE) Announces Oral Presentation on Clinical Benefits of Adjuvant Breast Cancer Vaccine at the American College of Surgeons Clinical Congress 2013 Galena Biopharma, a Portland
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 04, 2013 12:18pm
Galena Biopharma, Inc. (GALE) to Present at Upcoming Investo
Galena Biopharma, Inc. (GALE) to Present at Upcoming Investor Forum Today before the opening bell, Galena announced that Executive Vice President and Chief Operating Officer Mark W. Schwartz, Ph.D
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 03, 2013 6:05pm
Galena Biopharma, Inc. (GALE) Launches FDA-Approved Abstral®
Galena Biopharma, Inc. (GALE) Launches FDA-Approved Abstral® for Treatment of Breakthrough Cancer Pain Galena Biopharma, a biopharmaceutical company focused on developing and
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 25, 2013 5:40pm
Galena Biopharma, Inc. (GALE) Reports Closing of Over-Allotm
Galena Biopharma, Inc. (GALE) Reports Closing of Over-Allotment Option, Resulting in Total Gross Proceeds of $37.6M Galena Biopharma, a biopharmaceutical company developing and commercializing
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 23, 2013 6:27pm
Galena Biopharma, Inc. (GALE) Scheduled to Present at Upcomi
Galena Biopharma, Inc. (GALE) Scheduled to Present at Upcoming Biotech Industry Conference Galena Biopharma, a biopharmaceutical company focused on developing and commercializing targeted oncology
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 17, 2013 5:01pm
Galena Biopharma, Inc. (GALE) Mounts Multiple Successful Att
Galena Biopharma, Inc. (GALE) Mounts Multiple Successful Attacks on Cancer “I’ve had several friends who’ve had (breast cancer) and then . . . it came back and
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 10, 2013 4:30pm
Galena Biopharma, Inc. (GALE) Backed with High Expectations for Upcoming Abstral Launch
Galena Biopharma, Inc. (GALE) Backed with High Expectations for Upcoming Abstral Launch Each year, nearly 1.6 million new cases of cancer are diagnosed in the United States, excluding skin cancer
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 04, 2013 5:49pm
Galena Biopharma, Inc. (GALE) Scheduled to Present at the Rodman & Renshaw Annual Global Investment Conference
Galena Biopharma, Inc. (GALE) Scheduled to Present at the Rodman & Renshaw Annual Global Investment Conference Today before the opening bell, Galena Biopharma announced that its President and
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Sep 03, 2013 6:31pm
Galena Biopharma (GALE) Initiates RELIEF Patient Registry for Abstral®, Launches Sales Campaign
Galena Biopharma (GALE) Initiates RELIEF Patient Registry for Abstral®, Launches Sales Campaign Galena Biopharma, a Portland -based biopharmaceutical company focused on developing
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Aug 29, 2013 7:47pm
Galena Biopharma, Inc. (GALE) Written Up in The Motley Fool
Galena Biopharma, Inc. (GALE) Written Up in The Motley Fool The Motley Fool’s recent evaluation of Galena Biopharma (https://dtg.fm/Yrd6) left little doubt as to the company&
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Aug 21, 2013 3:47pm
Galena Biopharma, Inc. (GALE) European Allowance to Strengthen IP Portfolio
Galena Biopharma, Inc. (GALE) European Allowance to Strengthen IP Portfolio Galena Biopharma, a biopharmaceutical company developing and commercializing targeted oncology treatments that address major
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Aug 16, 2013 6:07pm
Needham Expounds on Galena Biopharma, Inc. (GALE) Valuation
Needham Expounds on Galena Biopharma, Inc. (GALE) Valuation Needham & Company LLC has initiated coverage on biopharmaceutical company Galena Biopharma with a “Buy” rating
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Aug 09, 2013 5:19pm
ROTH Maintains ‘Buy’ Rating, $7 Price Target for Galena Biopharma, Inc. (GALE)
ROTH Maintains ‘Buy’ Rating, $7 Price Target for Galena Biopharma, Inc. (GALE) In May, ROTH Capital Partners, LLC valuated biopharmaceutical company Galena Biopharma, Inc. with a
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Thematic Insights: Free Podcast Exploring Market Trends & Emerging Sectors
Flow Test and Laboratory Analysis Confirm a Major New HELIUM Discovery in Minnesota
This Small-Cap Gold Stock Keeps Notching Up High-Grade Gold in Nevada